Skip Navigation
Return to All Schools

Bloomberg Distinguished Professorship in RNA Biology and Therapeutics

School of Medicine, Zanvyl Krieger School of Arts and Sciences

Established in 2014 by Michael R. Bloomberg

MICHAEL R. BLOOMBERG is a Johns Hopkins alumnus, founder of Bloomberg LP and Bloomberg Philanthropies, World Health Organization Global Ambassador for Noncommunicable Diseases, UN Secretary-General’s Special Envoy for Climate Action, and former New York City mayor.

He is an entrepreneur and philanthropist who served as mayor of New York City from 2002-2013 after leading the company he started in 1981 for 20 years. Since leaving City Hall, he has resumed leadership of Bloomberg LP.

Bloomberg was elected mayor less than two months after the terrorist attacks of September 11, 2001. Under his leadership, the city rebounded faster and stronger than expected on issues ranging from education to health to economic development.

A lifelong philanthropist, Bloomberg founded Bloomberg Philanthropies, which focuses on five main areas: public health, education, the environment, the arts, and government innovation. He also leads a number of bi-partisan coalitions on urgent issues, including climate change, illegal guns, immigration reform, and infrastructure investment. In January 2013, he made the $350 million gift that established the Bloomberg Distinguished Professorships and provided undergraduate financial aid.

Bloomberg graduated from Johns Hopkins University and Harvard Business School.

Held by Jeffery Coller

JEFFERY COLLER has made seminal discoveries in the area of messenger RNA stability and translation. Working from ribosomes to patients, he is pushing open this exciting field with the aim of developing novel therapeutics for devastating rare diseases, improving gene therapy manufacturing and efficacy, and exploring novel disease diagnostics.

Coller studies the very essence of life: translation of the genetic code. His work has led to fundamental shifts in the understanding of gene expression by demonstrating that the genetic code is a major determinant of mRNA fate in eukaryotes, including humans. Coller examines the relationship between mRNA translation—a process in which messenger RNA is synthesized into a protein—and mRNA stability, focusing in particular on the pathways underlying mRNA degradation. He investigates what exactly signals the end of mRNA translation and the beginning of mRNA degradation, which is not yet understood but holds great potential for novel therapeutics.

Coller joined Johns Hopkins University as a Bloomberg Distinguished Professor in 2020 from Case Western Reserve University.